Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-02

Clinical Trial Update: Growth Hormone Treatment in Children With Phelan McDermid Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating growth hormone treatment in children with Phelan-McDermid syndrome has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Somatropin (somatropin)

Snippet

Sponsor: Swathi Sethuram | Conditions: Phelan McDermid Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2024-05-02